Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of inactivated split virion influenza vaccine in adults ≥60 years
CTR20255173Phase 2Active
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine, split virion, inactivated in influenza, sponsored by Shanghai Institute of Biological Products. Started Dec 2025; status: active.
02
Drugs
influenza vaccine, split virion, inactivated
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20255173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255173.